AdaptHealth director granted 18,999 RSUs

Coppens Bradley J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Coppens Bradley J reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. director Bradley J. Coppens reported receiving a grant of 18,999 shares of Common Stock in the form of restricted stock units, which will be settled in common stock upon vesting. Following this award, he directly holds a total of 96,345 shares.

Insider Trade Summary

Grant/Award: 18,999 shares

Grant/Award 1 txn

Insider Coppens Bradley J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00

Holdings After Transaction: Common Stock — 96,345 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

RSU grant size: 18,999 shares Price per share: $0.0000 Total holdings after grant: 96,345 shares

3 metrics

RSU grant size 18,999 shares Restricted stock units of Common Stock granted to director

Price per share $0.0000 Reported grant price per share for RSUs

Total holdings after grant 96,345 shares Common Stock directly owned by Bradley J. Coppens after transaction

Key Terms

restricted stock units, Form 4, Grant, award, or other acquisition

3 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) disclose in this Form 4?

AdaptHealth disclosed that director Bradley J. Coppens received a grant of 18,999 restricted stock units of Common Stock. The award is compensation-related, carries no purchase price, and increases his direct holdings reported after the transaction to 96,345 shares.

Was the AdaptHealth (AHCO) Form 4 transaction a purchase or a grant?

The Form 4 shows a grant or award, not an open-market purchase. Transaction code A indicates a grant, and the price per share is reported as 0.0000, confirming it was awarded as equity compensation rather than bought in the market.

How many AdaptHealth (AHCO) shares does Bradley J. Coppens hold after this grant?

After the reported grant, Bradley J. Coppens directly holds 96,345 shares of AdaptHealth Common Stock. This figure includes the 18,999 restricted stock units reported in the filing, which will ultimately settle in common shares when the units vest.

What type of equity did AdaptHealth (AHCO) grant to Bradley J. Coppens?

The filing states that the grant consists of restricted stock units tied to AdaptHealth Common Stock. According to the footnote, these units will be settled in actual common shares upon vesting, aligning the director’s compensation with future company performance.

Did Bradley J. Coppens pay cash for the new AdaptHealth (AHCO) shares?

No cash was paid for the new shares. The transaction lists a price per share of 0.0000, indicating the 18,999 restricted stock units were granted as compensation rather than purchased, consistent with the Form 4 transaction code A for an award acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coppens Bradley J

(Last) (First) (Middle)

C/O ONE EQUITY PARTNERS

510 MADISON AVENUE, 19TH FLOOR

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999(1)	A	$0	96,345	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Bradley J. Coppens	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)